Search
Now showing items 11-20 of 69
Comprehensive surgical treatment as the mainstay of management in retroperitoneal sarcomas: Retrospective study from two non-sarcoma specialist centers
(2017)
Background/Aim: Complete resection, surgical expertise and individualization of patient management in comprehensive oncology centres result in better clinical outcomes in patients presenting with retroperitoneal sarcomas. ...
Imaging in oncology-over a century of advances
(2012)
Over the past 120 years, the discipline of oncology has evolved so that a multitude of anatomical and increasingly complex functional imaging techniques are now applicable in both clinical and research platforms. This ...
The fate of new fosfamides in phase III studies in advanced soft tissue sarcoma
(2017)
For decades, doxorubicin alone or in combination with ifosfamide has been used in advanced soft tissue sarcoma (STS). In 2014, a comparison of doxorubicin alone versus the combination with ifosfamide (in the randomised ...
Beyond triple-negative breast cancer: The need to define new subtypes
(2010)
Advances in the systemic treatment of early breast cancer have led to significant improvements in survival for patients with hormone receptor- and/or HER2-positive disease. In recent years, interest has focused on tumors ...
Stage I testicular seminoma: Management and controversies
(2009)
Seminomas constitute more than half of testicular germ-cell tumours and 70-80% of patients with seminoma present with clinical stage I disease. Post-orchiectomy, management options include irradiation, surveillance or ...
Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy
(2019)
Improved understanding of the immune system and its role in cancer development and progression has led to impressive advances in the field of cancer immunotherapy over the last decade. Whilst the field is rapidly evolving ...
Molecular subtypes and emerging therapeutic opportunities
(Future Medicine Ltd., 2011)
Triple-negative breast cancers comprise a heterogeneous group of tumors with varying prognosis, but the majority are of high histological grade and have a poor prognosis. Although there is considerable overlap between ...
Pet in Breast Cancer
(2008)